120 related articles for article (PubMed ID: 21457725)
1. Advance notification letters increase adherence in colorectal cancer screening: a population-based randomized trial.
van Roon AH; Hol L; Wilschut JA; Reijerink JC; van Vuuren AJ; van Ballegooijen M; Habbema JD; van Leerdam ME; Kuipers EJ
Prev Med; 2011 Jun; 52(6):448-51. PubMed ID: 21457725
[TBL] [Abstract][Full Text] [Related]
2. An advance notification letter increases participation in colorectal cancer screening.
Cole SR; Smith A; Wilson C; Turnbull D; Esterman A; Young GP
J Med Screen; 2007; 14(2):73-5. PubMed ID: 17626705
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of an advance notification letter to increase colorectal cancer screening.
Cronin P; Goodall S; Lockett T; O'Keefe CM; Norman R; Church J
Int J Technol Assess Health Care; 2013 Jul; 29(3):261-8. PubMed ID: 23778152
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of targeted and tailored interventions on colorectal cancer screening use.
Lairson DR; DiCarlo M; Myers RE; Wolf T; Cocroft J; Sifri R; Rosenthal M; Vernon SW; Wender R
Cancer; 2008 Feb; 112(4):779-88. PubMed ID: 18098272
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening.
Myers RE; Sifri R; Hyslop T; Rosenthal M; Vernon SW; Cocroft J; Wolf T; Andrel J; Wender R
Cancer; 2007 Nov; 110(9):2083-91. PubMed ID: 17893869
[TBL] [Abstract][Full Text] [Related]
6. [Colorectal cancer screening: advice from the Health Council of the Netherlands].
van Veen W; Mali WP
Ned Tijdschr Geneeskd; 2009; 153():A1441. PubMed ID: 20003552
[TBL] [Abstract][Full Text] [Related]
7. Direct mailing of faecal occult blood tests for colorectal cancer screening: a randomized population study from Central Italy.
Giorgi Rossi P; Grazzini G; Anti M; Baiocchi D; Barca A; Bellardini P; Brezzi S; Camilloni L; Falini P; Maccallini V; Mantellini P; Romeo D; Rubeca T; Venditti MA
J Med Screen; 2011; 18(3):121-7. PubMed ID: 22045820
[TBL] [Abstract][Full Text] [Related]
8. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
Inadomi JM
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
[TBL] [Abstract][Full Text] [Related]
9. Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans.
Wolf MS; Fitzner KA; Powell EF; McCaffrey KR; Pickard AS; McKoy JM; Lindenberg J; Schumock GT; Carson KR; Ferreira MR; Dolan NC; Bennett CL
J Clin Oncol; 2005 Dec; 23(34):8877-83. PubMed ID: 16314648
[TBL] [Abstract][Full Text] [Related]
10. Theory-based modifications of an advanced notification letter improves screening for bowel cancer in men: A randomised controlled trial.
Zajac IT; Duncan AC; Flight I; Wittert GA; Cole SR; Young GP; Wilson CJ; Turnbull DA
Soc Sci Med; 2016 Sep; 165():1-9. PubMed ID: 27485727
[TBL] [Abstract][Full Text] [Related]
11. The safety net: a cost-effective approach to improving breast and cervical cancer screening.
Vogt TM; Glass A; Glasgow RE; La Chance PA; Lichtenstein E
J Womens Health (Larchmt); 2003 Oct; 12(8):789-98. PubMed ID: 14588129
[TBL] [Abstract][Full Text] [Related]
12. Comparison of mailed invitation strategies to improve fecal occult blood test participation in men: protocol for a randomized controlled trial.
Duncan A; Zajac I; Flight I; Stewart BJ; Wilson C; Turnbull D
Trials; 2013 Jul; 14():239. PubMed ID: 23902589
[TBL] [Abstract][Full Text] [Related]
13. Improving uptake of screening for colorectal cancer: a study on invitation strategies and different test kit use.
Santare D; Kojalo I; Huttunen T; Rikacovs S; Rucevskis P; Boka V; Leja M
Eur J Gastroenterol Hepatol; 2015 May; 27(5):536-43. PubMed ID: 25806603
[TBL] [Abstract][Full Text] [Related]
14. Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns.
Schroy PC; Barrison AF; Ling BS; Wilson S; Geller AC
Am J Gastroenterol; 2002 Apr; 97(4):1031-6. PubMed ID: 12008667
[TBL] [Abstract][Full Text] [Related]
15. Getting adequate information across to colorectal cancer screening subjects can be difficult.
van Rijn AF; van Rossum LG; Deutekom M; Laheij RJ; Bossuyt PM; Fockens P; Dekker E; Jansen JB
J Med Screen; 2008; 15(3):149-52. PubMed ID: 18927098
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
17. Invitation strategies for colorectal cancer screening programmes: The impact of an advance notification letter.
Senore C; Ederle A; DePretis G; Magnani C; Canuti D; Deandrea S; Zorzi M; Barca A; Bestagini P; Faitini K; Bisanti L; Casale C; Ferro A; GiorgiRossi P; Quadrino F; Fiorina G; Capuano A; Segnan N; Fantin A
Prev Med; 2015 Apr; 73():106-11. PubMed ID: 25602908
[TBL] [Abstract][Full Text] [Related]
18. Attitudes, knowledge and practice of CRC screening among GPs in Queensland.
Youl PH; Jackson C; Oldenburg B; Brown C; Dunn J; Aitken J
Aust Fam Physician; 2006 Jul; 35(7):547-50. PubMed ID: 16820832
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16).
Chen LS; Liao CS; Chang SH; Lai HC; Chen TH
J Med Screen; 2007; 14(4):191-9. PubMed ID: 18078564
[TBL] [Abstract][Full Text] [Related]
20. A cost-effectiveness comparison of three tailored interventions to increase mammography screening.
Saywell RM; Champion VL; Skinner CS; Menon U; Daggy J
J Womens Health (Larchmt); 2004 Oct; 13(8):909-18. PubMed ID: 15671706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
